https://www.financialexpress.com/healthcare/pharma-healthcare/usfda-pulls-up-intas-pharma-for-manufacturing-lapses-at-ahmedabad-plant/3334464/
A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations.
Create an account or login to join the discussion